Search for: "TEVA BRANDED PHARMACEUTICAL PRODUCTS R"
Results 1 - 20
of 96
Sorted by Relevance
|
Sort by Date
9 Sep 2012, 9:59 pm
Teva Branded Pharmaceutical Products R&D Inc. et al. v. [read post]
3 Apr 2024, 1:07 pm
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
25 Sep 2008, 4:23 am
According to Teva's release, the company's G-CSF product, which will be marketed in Europe under the brand name TevaGrastim ® beginning in 2009, is the first G-CSF biosimilar to receive a marketing authorization in the EU.... [read post]
28 Dec 2017, 2:44 am
How to right the ship with respect to its generic products, while also ramping up the necessary R&D to support a viable proprietary drug business, is daunting for even the largest pharmaceutical company. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
5 Dec 2022, 6:55 am
In Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
14 May 2014, 9:03 am
Teva Branded Pharmaceutical Products R&D, Inc., et al. v. [read post]
13 Oct 2012, 3:30 pm
Teva Pharmaceutical Industries Ltd makes this generic drug as well as many other generic drugs. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
25 Nov 2012, 5:42 pm
By Kurt R. [read post]
15 May 2019, 5:27 am
Kluwer Patent blogger44 U.S. states filed a lawsuit last Friday accusing Teva Pharmaceuticals USA of conspiring illegally with 19 other drug companies to inflate drug prices – sometimes by more than 1,000 percent – and stifle competition for generic drugs. [read post]
2 Oct 2013, 8:58 am
Teva Pharmaceuticals USA et al. [read post]
24 Aug 2021, 2:10 am
The Hatch-Waxman Act allows the FDA to permit a generic version of a branded product, which is partially patent protected, to come to market if the generic manufacturer “carves out” the patent-protected indication from its label. [read post]
17 Jun 2011, 2:25 am
The Bedford Report keeps an eye on healthcare companies and provides research reports on Teva Pharmaceutical Industries Limited (makers of generic Yasmin) and Mylan Inc., the makers of Effexor. [read post]
21 Jan 2011, 6:38 am
By Kurt R. [read post]
9 Jun 2014, 2:28 pm
They must use the same exact wording on their products’ labels. [read post]
12 Nov 2009, 9:17 am
Teva Pharmaceuticals USA, Inc., 2007 WL 5787186, at *2-3 (S.D. [read post]
25 Oct 2011, 9:28 am
Court of Appeals for the 2nd Circuit that found a pay for delay deal between Bayer AG and Barr Pharmaceuticals (now owned by Teva Pharmaceuticals) to drop a patent lawsuit over the antibiotic Cipro did not violate antitrust laws. [read post]
